S. Mimuro et al., CHANGES OF RESISTANCE TO ACTIVATED PROTEIN-C IN THE COURSE OF PREGNANCY AND PREVALENCE OF FACTOR-V MUTATION, Australian and New Zealand Journal of Obstetrics and Gynaecology, 38(2), 1998, pp. 200-204
The purpose of this study was to examine the changes in activated prot
ein C (APC) anticoagulant activity during pregnancy and determine whet
her changes in APC could contribute to thrombosis in the placental bed
in preeclampsia. We measured APC anticoagulant activity in 150 women
with a normal pregnancy and 50 women with preeclampsia. There was a si
gnificant reduction in the mean APC sensitivity ratio (APC-SR) during
pregnancy (p<0.001). APC resistance in preeclampsia was significantly
higher than in normal pregnancy (p<0.01). Amongst women with APC resis
tance the presence of the factor V Leiden mutation was significantly h
igher in the preeclampsia group than in the normal pregnancy group (p<
0.01). It seems that both factor V Leiden mutation and APC resistance
may be associated with the development of preeclampsia. These results
suggest that APC resistance may be an important mechanism underlying p
lacental bed pathology in pregnancy and may be associated with an incr
eased tendency to develop preeclampsia in some women. Assay of APC res
istance and factor V Leiden mutation should be performed in women with
preeclampsia.